Form 485BXT Brighthouse Life Insuran
As filed with the Securities and
Exchange Commission on March 20, 2026
Registration Number 333-290025
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form N-4
| REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 |
|
| Pre-Effective Amendment No. |
☐ |
| Post-Effective Amendment No. 5 |
☒ |
Brighthouse Life Insurance Company
(Name of Insurance Company)
11225 North Community House Road, Charlotte, NC 28277
(Address of Insurance Company’s Principal Executive Offices) (Zip Code)
(Address of Insurance Company’s Principal Executive Offices) (Zip Code)
(980) 365-7100
(Insurance Company’s Telephone Number, including area code)
(Insurance Company’s Telephone Number, including area code)
Brighthouse Life Insurance Company
c/o The Corporation Trust Company
1209 Orange Street
Corporation Trust Center
New Castle County
Wilmington, DE 19801
(800) 448-5350
(Name and Address of Agent for Service)
c/o The Corporation Trust Company
1209 Orange Street
Corporation Trust Center
New Castle County
Wilmington, DE 19801
(800) 448-5350
(Name and Address of Agent for Service)
Copies to:
Dodie C. Kent
Ronald Coenen, Jr.
Eversheds Sutherland (US) LLP
The Grace Building, 40th Floor
1114 Avenue of the Americas
New York, NY 10036-7703
Ronald Coenen, Jr.
Eversheds Sutherland (US) LLP
The Grace Building, 40th Floor
1114 Avenue of the Americas
New York, NY 10036-7703
Approximate Date of Proposed Public Offering: Continuously after the registration statement becomes
effective.
It is proposed that this filing will become effective (check appropriate box):
☐ immediately upon filing pursuant to paragraph (b)
☒ on April 19, 2026 pursuant to paragraph (b)
☐ 60 days after
filing pursuant to paragraph (a)(1)
☐ on (date) pursuant to paragraph (a)(1) of rule 485 under the Securities Act.
If appropriate, check the following box:
☒ This
post-effective amendment designates a new effective date for a previously filed post-effective amendment.
Check each box that appropriately characterizes the Registrant:
☐ New Registrant (as applicable, a Registered Separate Account or Insurance Company that has not
filed a Separate Account or Insurance Company or amendment thereto within 3 years preceding this filing)
☐ Emerging Growth Company (as defined by Rule 12b-2 under the Securities Exchange
Act of 1934 (“Exchange Act”))
☐ If an Emerging Growth Company, indicate by check mark if the
Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act
☐ Insurance Company relying on Rule 12h-7 under the Exchange Act
☐ Smaller
reporting company (as defined by Rule 12b-2 under the Exchange Act
This Post-Effective Amendment is being filed pursuant to rule 485(b)(1)(iii) under the Securities Act of 1933, as amended,
for the sole purpose of delaying the effective date of Post-Effective Amendment No. 1 (“Amendment No. 1”) to Registration Statement File No. 333-290025 filed pursuant
to rule 485(a) under the Securities Act of 1933, as amended, on October 7, 2025.
Parts A, B and C were filed in Amendment No. 1 and are incorporated by reference herein. Powers of attorney filed
herewith.
Signatures
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it
meets all the requirements for effectiveness of this registration statement under rule 485(b) under the Securities Act and has duly caused this registration statement to be signed on its behalf by the undersigned, duly authorized, in the City of Charlotte, and State
of North Carolina, on the 18th day of March, 2026.
| By: |
BRIGHTHOUSE LIFE INSURANCE COMPANY |
| |
(Insurance Company) |
| By: |
/s/ David A.
Rosenbaum |
| |
David A. Rosenbaum
Vice President |
Pursuant to the requirement of the Securities Act
of 1933, this registration statement has been signed by the following persons in the capacities indicated on March 18, 2026.
| /s/ Eric T. Steigerwalt* Eric T. Steigerwalt
|
Chairman of the Board, President, Chief Executive Officer and a Director |
| /s/ Myles J. Lambert* Myles J. Lambert
|
Director |
| /s/ David A. Roenbaum* David A. Rosenbaum
|
Director |
| /s/ John L. Rosenthal* John L. Rosenthal
|
Director |
| /s/ Edward A. Spehar* Edward A. Spehar
|
Director, Vice President and Chief Financial Officer |
| /s/ Melissa B. Pavlolich* Melissa B. Pavlovich
|
Vice President and Chief Accounting Officer |
| /s/ Gianna H. Figaro-Sterling* Gianna H.
Figaro-Sterlilng |
Vice President and Controller |
| *By: |
/s/ Michele H.
Abate |
| |
Michele H. Abate
Attorney-in-Fact, March 18, 2026 |
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KlarFX.com Reviews SpaceX IPO
- MindMaze Therapeutics Announces Results of Annual General Meeting
- BrandGap.AI gives every brand decision an objective, evidence-based foundation that's built in minutes, not days
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share